1-3 of 3
Rupa Narayan
Close
Sort by
Journal Articles

Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2 -mutated myeloid malignancies

Clinical Trials & Observations
Amir T. Fathi, Haesook T. Kim, Robert J. Soiffer, Mark J. Levis, Shuli Li, Annette S. Kim, Alice S. Mims, Zachariah DeFilipp, Areej El-Jawahri, Steven L. McAfee, Andrew M. Brunner, Rupa Narayan, Laura W. Knight, Devon Kelley, AJ S. Bottoms, Lindsey H. Perry, Jonathan L. Wahl, Jennifer Brock, Elayne Breton, Vincent T. Ho, Yi-Bin Chen
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5857–5865.
https://doi.org/10.1182/bloodadvances.2022008632
Published: 2022
Includes: Supplemental data
Journal Articles

Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

Clinical Trials & Observations
Monica Kasbekar, Valentina Nardi, Paola Dal Cin, Andrew M. Brunner, Meghan Burke, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, Julia Foster, Molly Macrae, Steven L. McAfee, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, Meghan Vartanian, Robb S. Friedman, Karim A. Benhadji, Gabriela S. Hobbs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3136–3140.
https://doi.org/10.1182/bloodadvances.2020002308
Published: 2020
Journal Articles

Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement

Clinical Trials & Observations
Valentina Nardi, Nora Ku, Matthew J. Frigault, Adrian M. Dubuc, Harrison Kwei Tsai, Philip C. Amrein, Gabriela S. Hobbs, Andrew M. Brunner, Rupa Narayan, Meghan E. Burke, Julia Foster, Paola Dal Cin, Marcela V. Maus, Amir T. Fathi, Hanno Hock
Journal: Blood Advances
Blood Adv (2020) 4 (1): 106–111.
https://doi.org/10.1182/bloodadvances.2019000769
Published: 2020
Includes: Supplemental data